News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Post Navigation Previous Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Healthcare News HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference Staff December 23, 2024 Clinical Trial News Pharmaceutical Glaukos Submits New Drug Application to U.S. FDA for Epioxa™ Staff December 23, 2024 Cancer News Pharmaceutical The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids Staff December 23, 2024
